Related Experiment Video
Updated: May 16, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Corneal depositions in tyrosinaemia type I during treatment with Nitisinone
Robert P L Wisse1, Dienke Wittebol-Post, Gepke Visser
1Department of Ophthalmology, UMC Utrecht, Utrecht, The Netherlands. r.p.l.wisse@umcutrecht.nl
Abstract:
We present a 17-year-old boy, diagnosed with tyrosinaemia type I at an age of 7 months, with new complaints of severe intermittent photophobia and burning eyes. His tyrosinaemia type I is treated with nitisinone and a protein-restricted diet. Dietary compliance is low since he entered puberty. His ocular complaints are attributable to subepithelial corneal deposits, resembling the common corneal phenotype of tyrosinaemia type II. Serum tyrosine levels were markedly elevated. Tyrosinaemia is a metabolic disease of tyrosine metabolism, subdivided into two types. Corneal deposits and photophobia are cardinal features of untreated tyrosinaemia type II, but not of type I. Novel treatment strategies (with nitisinone) for type I tyrosinaemia lead to a phenotype comparable with type II, including these corneal deposits. At follow-up visits his ocular complaints unfortunately remained unchanged, though he states his dietary compliance improved through the years.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Diabetic Retinopathy
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease II: Clinical Manifestations
Diabetic Nephropathy
Nephrotic Syndrome III : Nursing Management
